SCHEMBL69929

SCHEMBL69929

NCc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL31511835 0.97
Hydrochloric Acid SCHEMBL399515 0.97 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL399517 0.97
Hydrochloric Acid SCHEMBL245201 0.97
Bromide SCHEMBL31511833 0.97
SCHEMBL659365 0.80
Hydrochloric Acid SCHEMBL17184356 0.78 ALDH1A1 (0.42)
Hydrochloric Acid SCHEMBL1028586 0.78
SCHEMBL3787961 0.78 FDPS (0.47)
SCHEMBL8671012 0.78 FDPS (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12157717-B2 Compounds for the treatment of bovine or swine respiratory disease INTERVET INC. (US) 2024-12-03 US claimed
CN-117750864-A Self-spreadable perovskite precursor solution with layered structure, material and solar cell 浙江大学 2024-03-22 CN claimed
CN-114213395-B Pyrimidone acyl piperazine compound and preparation method and application thereof 山东大学 2022-10-25 CN claimed
CN-109563085-B Piperidine CXCR7 receptor modulators 爱杜西亚药品有限公司 2022-08-09 CN claimed
CN-114213395-A Pyrimidone acyl piperazine compound and preparation method and application thereof 山东大学 2022-03-22 CN claimed
EP-3490986-B1 PIPERIDINE CXCR7 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-11-24 EP claimed
US-20210347730-A1 COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE INTERVET INC. (US) 2021-11-11 US claimed
US-11034650-B2 Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection INTERVET INC. (US) 2021-06-15 US claimed
EP-3810571-A1 COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE Intervet International B.V. (NL) 2021-04-28 EP claimed
US-10752620-B2 Piperdine CXCR7 receptor modulators IDORSIA PHARMACEUTICALS LTD. (CH) 2020-08-25 US claimed
US-20060014796-A1 Epothilone derivatives DENNI-DISCHERT DONATIENNE 2006-01-19 US claimed
WO-2005097750-A1 SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) AVENTIS PHARMACEUTICALS INC. (US) 2005-10-20 WO claimed
EP-1581536-A2 EPOTHILONE DERIVATIVES Novartis AG (CH) 2005-10-05 EP claimed
CN-1194967-C Heterocyclic ring contained methylamine cyanoacrylate compound and weeding activity UNIV NANKAI (CN) 2005-03-30 CN claimed
WO-2004056832-A2 EPOTHILONE DERIVATIVES NOVARTIS AG (CH) 2004-07-08 WO claimed
CN-1483320-A Heterocyclic ring contained methylamine cyanoacrylate compound and weeding activity 南开大学 2004-03-24 CN claimed
US-20040043984-A1 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors O'BRIEN PATRICK MICHAEL (US) 2004-03-04 US claimed
WO-2004014389-A1 3,4-DIHYDROQUINOLIN-2-ONE, 5,6-FUSED OXAZIN-3-ONE, AND 5,6-FUSED THIAZIN-3-ONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO claimed
US-4690921-A BACTERICIDES YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1987-09-01 US claimed
EP-0142274-A2 Cephalosporin compounds and salts thereof, their production, and medicaments containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1985-05-22 EP claimed